Tight control of serum glucose levels is critically important in reducing long-term complications of diabetes mellitus. Accumulating evidence suggests that these long-term benefits are not risk-free, and that recurrent episodes of hypoglycemia, or severe hypoglycemic coma secondary to incorrect insulin dosing, have significant morbidity. Damage to the hippocampus and cerebral cortex has been noted, as have cognitive defects in humans and in animal models. However, the mechanisms that underlie hypoglycemic damage to the nervous system, particularly during embryogenesis, remain largely unknown. We propose to better define how neurons are damaged by hypoglycemia in the nervous system, whether synaptic connectivity and neuronal development are affected, and whether hypoglycemia triggers expression of particular genes within the brain, providing insight into the type of damage that is sustained and identifying possible avenues of therapeutic intervention. Using two complementary hippocampal primary culture models, we plan to identify the pathways that lead to neuronal injury in response to hypoglycemia (Specific Aim I). Neuronal vulnerability to cell death will be determined; type of cell death, death pathways and active intermediates, and the transmitter phenotypes of the affected hippocampal neurons will be defined. In addition, effects of hypoglycemia to delay or disrupt neuronal polarization, axonal and dendritic outgrowth, selective axonal and dendritic protein transport, and synaptogenesis will be analyzed. Since recurrent bouts of hypoglycemia in utero are associated with postnatal cognitive impairment, we propose to examine whether cell death pathways are activated in the hippocampus through exposure to hypoglycemia in utero (Aim II). In addition, we propose to identify genes that are regulated in the embryonic and early post-natal hippocampus by hypoglycemia, which we hope will offer insight into the mechanism(s) by which the hippocampus is damaged.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS045305-01
Application #
6576294
Study Section
Special Emphasis Panel (ZNS1-SRB-A (03))
Program Officer
Behar, Toby
Project Start
2002-09-30
Project End
2006-07-31
Budget Start
2002-09-30
Budget End
2003-07-31
Support Year
1
Fiscal Year
2002
Total Cost
$316,760
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Neurosciences
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Sakurai, Takeshi; Gil, Orlando D; Whittard, John D et al. (2008) Interactions between the L1 cell adhesion molecule and ezrin support traction-force generation and can be regulated by tyrosine phosphorylation. J Neurosci Res 86:2602-14
Mintz, C David; Carcea, Ioana; McNickle, Daniel G et al. (2008) ERM proteins regulate growth cone responses to Sema3A. J Comp Neurol 510:351-66
Hunsberger, Joshua G; Newton, Samuel S; Bennett, Alicia H et al. (2007) Antidepressant actions of the exercise-regulated gene VGF. Nat Med 13:1476-82
Chakraborty, Tandra R; Tkalych, Oleg; Nanno, Daniela et al. (2006) Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress. Brain Res 1089:21-32
Garcia, Angelo L; Han, Shan-Kuo; Janssen, William G et al. (2005) A prohormone convertase cleavage site within a predicted alpha-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway. J Biol Chem 280:41595-608
Mobbs, Charles V; Yen, Kelvin; Mastaitis, Jason et al. (2004) Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression. Neurochem Res 29:1093-103
Mintz, C David; Dickson, Tracey C; Gripp, Mark L et al. (2003) ERMs colocalize transiently with L1 during neocortical axon outgrowth. J Comp Neurol 464:438-48